How to talk with parents about the recent Pfizer/BioNTech news for the youngest kids

Video

Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how to help parents who are worried or nervous about the delay in the expansion of the Pfizer/BioNTech vaccine to children aged 6 months to younger than 4 years.

Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how to help parents who are worried or nervous about the delay in the expansion of the Pfizer/BioNTech vaccine to children aged 6 months to younger than 4 years.

Recent Videos
Russell Libby, MD, FAAP
Lawrence Eichenfield, MD
Brittany Bruggeman, MD
Octavio Ramilo, MD
Lynn Malec, MD
Related Content
FDA approves pz-cel for recessive dystrophic epidermolysis bullosa | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves pz-cel for recessive dystrophic epidermolysis bullosa

Joshua Fitch, Senior Editor
Published: April 29th 2025 | Updated: April 29th 2025
Article

The decision makes pz-cel the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with RDEB.

Pegtarazimod data confirms inflammation biomarkers in hypoxic ischemic encephalopathy infants | Image Credit: © Carl - © Carl - stock.adobe.com.

Pegtarazimod data confirms inflammation biomarkers in hypoxic ischemic encephalopathy infants

Joshua Fitch, Senior Editor
April 25th 2025
Article

In addition, data presented at PAS revealed a predictable pharmacokinetic profile in the newborn population, consistent with adult humans.

Weekly review: FDA approves dupilumab, ACIP meets, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: FDA approves dupilumab, ACIP meets, and more

Joshua Fitch, Senior Editor
April 21st 2025
Article

From the FDA approvals of dupilumab and maralixibat tablets to a new puzzler case study, get caught up with our weekly review article.

FDA issues CRL for aflibercept 8 mg extended dosing for all indications | Image Credit: © Araki Illustrations - stock.adobe.com.

FDA issues CRL for aflibercept 8 mg extended dosing for all indications

Joshua Fitch, Senior Editor
April 18th 2025
Article

The CRL issued by the FDA to Regeneron for extended EYLEA HD dosing to 24 weeks cited no safety or efficacy concerns.

FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up

Joshua Fitch, Senior Editor
April 18th 2025
Article

The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU.

FDA expands diazepam nasal spray for seizure clusters to ages 2–5 | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA expands diazepam nasal spray for seizure clusters to ages 2–5

Joshua Fitch, Senior Editor
April 16th 2025
Article

Diazepam nasal spray (Valtoco) is approved for short-term treatment of seizure clusters, now in patients aged 2 years and older.

© 2025 MJH Life Sciences

All rights reserved.